DCAT Value Chain Insights

Emerging Pharma: Roivant Sciences on the Rise

With a $3-billion strategic alliance with Sumitomo Dainippon Pharma in the offing, Vivek Ramaswamy, CEO and founder of Roivant Sciences, is looking to take its “hub and spoke” business model for...

US House Drug Pricing Plan: Costs and the Impact on Pharma

The US Congressional Budget Office and the staff of the Joint Committee on Taxation have provided an analysis of the proposed drug pricing plan highlighted last month by US House of Representatives...

A winning pediatric dosage formulation

Information
March 6, 2019
Sponsored by Cambrex

When a global pharmaceutical company’s pediatric formulation and dosage form(s) didn’t fit the plant equipment profile used to manufacture the adult dosage form at the customer’s facility, they...

Read More
Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More